205 related articles for article (PubMed ID: 35269395)
1. Platelet Storage Pool Deficiency and Elevated Inflammatory Biomarkers Are Prevalent in Postural Orthostatic Tachycardia Syndrome.
Gunning WT; Kramer PM; Cichocki JA; Karabin BL; Khuder SA; Grubb BP
Cells; 2022 Feb; 11(5):. PubMed ID: 35269395
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory Biomarkers in Postural Orthostatic Tachycardia Syndrome with Elevated G-Protein-Coupled Receptor Autoantibodies.
Gunning WT; Stepkowski SM; Kramer PM; Karabin BL; Grubb BP
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33562074
[TBL] [Abstract][Full Text] [Related]
3. Postural orthostatic tachycardia syndrome is associated with platelet storage pool deficiency.
Gunning WT; Karabin BL; Blomquist TM; Grubb BP
Medicine (Baltimore); 2016 Sep; 95(37):e4849. PubMed ID: 27631244
[TBL] [Abstract][Full Text] [Related]
4. Postural Orthostatic Tachycardia Syndrome Is Associated With Elevated G-Protein Coupled Receptor Autoantibodies.
Gunning WT; Kvale H; Kramer PM; Karabin BL; Grubb BP
J Am Heart Assoc; 2019 Sep; 8(18):e013602. PubMed ID: 31495251
[TBL] [Abstract][Full Text] [Related]
5. Serum Activity Against G Protein-Coupled Receptors and Severity of Orthostatic Symptoms in Postural Orthostatic Tachycardia Syndrome.
Kharraziha I; Axelsson J; Ricci F; Di Martino G; Persson M; Sutton R; Fedorowski A; Hamrefors V
J Am Heart Assoc; 2020 Aug; 9(15):e015989. PubMed ID: 32750291
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune basis for postural tachycardia syndrome.
Li H; Yu X; Liles C; Khan M; Vanderlinde-Wood M; Galloway A; Zillner C; Benbrook A; Reim S; Collier D; Hill MA; Raj SR; Okamoto LE; Cunningham MW; Aston CE; Kem DC
J Am Heart Assoc; 2014 Feb; 3(1):e000755. PubMed ID: 24572257
[TBL] [Abstract][Full Text] [Related]
7. Detection of G Protein-Coupled Receptor Autoantibodies in Postural Orthostatic Tachycardia Syndrome Using Standard Methodology.
Hall J; Bourne KM; Vernino S; Hamrefors V; Kharraziha I; Nilsson J; Sheldon RS; Fedorowski A; Raj SR
Circulation; 2022 Aug; 146(8):613-622. PubMed ID: 35766055
[TBL] [Abstract][Full Text] [Related]
8. Antiadrenergic autoimmunity in postural tachycardia syndrome.
Fedorowski A; Li H; Yu X; Koelsch KA; Harris VM; Liles C; Murphy TA; Quadri SMS; Scofield RH; Sutton R; Melander O; Kem DC
Europace; 2017 Jul; 19(7):1211-1219. PubMed ID: 27702852
[TBL] [Abstract][Full Text] [Related]
9. G protein-coupled receptors related to autoimmunity in postural orthostatic tachycardia syndrome.
Sunami Y; Sugaya K; Takahashi K
Immunol Med; 2024 Jun; ():1-8. PubMed ID: 38900132
[TBL] [Abstract][Full Text] [Related]
10. Association of autoantibodies to muscarinic acetylcholine receptors with gastrointestinal symptoms and disease severity in patients with postural orthostatic tachycardia syndrome.
Sunami Y; Sugaya K; Miyakoshi N; Iwazaki O; Takahashi K
Immunol Res; 2022 Apr; 70(2):197-207. PubMed ID: 34993884
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis reveals sex-specific biomarker signature in postural orthostatic tachycardia syndrome.
Medic Spahic J; Ricci F; Aung N; Hallengren E; Axelsson J; Hamrefors V; Melander O; Sutton R; Fedorowski A
BMC Cardiovasc Disord; 2020 Apr; 20(1):190. PubMed ID: 32321428
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome.
Yu X; Li H; Murphy TA; Nuss Z; Liles J; Liles C; Aston CE; Raj SR; Fedorowski A; Kem DC
J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29618472
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis and follow-up study of postural orthostatic tachycardia syndrome in 28 pediatric cases].
Zhang QY; Du JB; Li WZ
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):165-9. PubMed ID: 15833184
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of cerebral oximetry in patients with postural orthostatic tachycardia syndrome.
Kharraziha I; Holm H; Bachus E; Melander O; Sutton R; Fedorowski A; Hamrefors V
Europace; 2019 Oct; 21(10):1575-1583. PubMed ID: 31384930
[TBL] [Abstract][Full Text] [Related]
15. Plasma proteomic profiling in postural orthostatic tachycardia syndrome (POTS) reveals new disease pathways.
Johansson M; Yan H; Welinder C; Végvári Á; Hamrefors V; Bäck M; Sutton R; Fedorowski A
Sci Rep; 2022 Nov; 12(1):20051. PubMed ID: 36414707
[TBL] [Abstract][Full Text] [Related]
16. [A case of chronic postural tachycardia syndrome with positive anti-ganglionic acetylcholine receptor (gAChR) antibody].
Goto Y; Sunami Y; Sugaya K; Nakane S; Takahashi K
Rinsho Shinkeigaku; 2021 Aug; 61(8):547-551. PubMed ID: 34275953
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune markers and autoimmune disorders in patients with postural tachycardia syndrome (POTS).
Blitshteyn S
Lupus; 2015 Nov; 24(13):1364-9. PubMed ID: 26038344
[TBL] [Abstract][Full Text] [Related]
18. Dysregulations in hemostasis, metabolism, immune response, and angiogenesis in post-acute COVID-19 syndrome with and without postural orthostatic tachycardia syndrome: a multi-omic profiling study.
Mahdi A; Zhao A; Fredengren E; Fedorowski A; Braunschweig F; Nygren-Bonnier M; Runold M; Bruchfeld J; Nickander J; Deng Q; Checa A; Desta L; Pernow J; Ståhlberg M
Sci Rep; 2023 Nov; 13(1):20230. PubMed ID: 37981644
[TBL] [Abstract][Full Text] [Related]
19. Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis.
Kanjwal K; Karabin B; Kanjwal Y; Grubb BP
Int J Med Sci; 2010 Mar; 7(2):62-7. PubMed ID: 20309394
[TBL] [Abstract][Full Text] [Related]
20. Postural tachycardia syndrome: a heterogeneous and multifactorial disorder.
Benarroch EE
Mayo Clin Proc; 2012 Dec; 87(12):1214-25. PubMed ID: 23122672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
